Zobrazeno 1 - 10
of 61
pro vyhledávání: '"R Veroz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. L. Martín-Varillas, L. Sanchez-Bilbao, V. Calvo-Río, A. Adan, I. Hernanz Rodriguez, E. Beltrán, S. Castro, P. Fanlo Mateo, A. García Martos, I. Torre-Salaberri, M. Cordero-Coma, J. De Dios-Jiménez Aberásturi, Á. García-Aparicio, M. Hernández-Garfella, A. Sanchez-Andrade, A. García-Valle, R. Miguélez, O. Maiz, S. Rodríguez Montero, A. Urruticoechea-Arana, R. Veroz Gonzalez, A. Conesa, C. Fernández-Carballido, V. Jovani, O. Martínez González, P. Moya, S. Romero-Yuste, P. Rubio Muñoz, E. Peña Sainz-Pardo, M. Garijo Bufort, J. L. Hernández, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:1013.2-1014
BackgroundAdalimumab remains the only biologic approved by the EMA and FDA for the treatment of non-infectious uveitis [1-6]. The reports on efficacy of other anti-TNF drugs such as Certolizumab Pegol (CZP) are scarce.Objectivesto determine the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b04beb95dc0d936b205cfb986e0969c
https://doi.org/10.1136/annrheumdis-2022-eular.3049
https://doi.org/10.1136/annrheumdis-2022-eular.3049
Autor:
V. Llorenç, M. Sainz-de-la-Maza, Á. García-Aparicio, A. Blanco, C. Hernando-Hernández, J. Cincunegui-Gutiérrez, P. Fanlo, H. Heras, O. García-García, M. Hernández-Garfella, R. Veroz Gonzalez, L. Rodriguez-Melian, V. Jovani
Publikováno v:
Annals of the Rheumatic Diseases. 81:1003-1003
BackgroundA personalized disease-specific treatment for non-infectious uveitis (NIU) is challenging. Around 50% of adults with NIU who required classic DMARDs or adalimumab in clinical trials, failed at 6 months during open label phase [1,2]. Therefo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef9057aa52da90ef010393f811c0e57f
https://doi.org/10.1136/annrheumdis-2022-eular.1211
https://doi.org/10.1136/annrheumdis-2022-eular.1211
Autor:
Fernando Gomollón, J. Campos, María Chaparro, Y. González-Lama, G. Bastida, R. Veroz, E. Domènech, B. Sicilia, X. Juanola, B. Joven, M Esteve, Ana Gutiérrez, J. Sanz, R. Ferreiro, J.P. Gisbert
Publikováno v:
Enfermedad Inflamatoria Intestinal al Día. 16:1-14
Resumen Las manifestaciones extraintestinales en general y, de entre ellas, las articulares en particular, suponen un problema frecuente en los pacientes con enfermedad inflamatoria intestinal. De hecho, la relacion entre ambas entidades parece estre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2b1887c5116384355f77d9344cc1f3a
https://doi.org/10.1016/j.eii.2016.09.002
https://doi.org/10.1016/j.eii.2016.09.002
Autor:
E. Chamizo Carmona, R. Veroz Gonzalez, L. M. Chaves Chaparro, J. J. Aznar Sanchez, I. Braña Abascal, M. Priego Fernandez-Martos, D. Fernandez Lozano, S. M. Rojas Herrera, J. Malave Calzada
Publikováno v:
Annals of the Rheumatic Diseases. 79:1718-1719
Background:Axial involvement in patients diagnosed of Psoriatic arthritis (PsA) in variable in previous studies. Axial involvement (according GRAPPA criteria) is based upon inflammatory spinal symptoms pain with loss of lumbar mobility and the presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f751f651920f03071fac637edcb7e1be
https://doi.org/10.1136/annrheumdis-2020-eular.6270
https://doi.org/10.1136/annrheumdis-2020-eular.6270
Autor:
Marcelino Revenga, Vanesa Calvo-Río, José L. Hernández, Elia Valls-Pascual, Santos Castañeda, Ricardo Blanco, M. Fernández, M. A. González-Gay, R. Veroz Gonzalez, F. J. Toyos Sáenz de Miera, Andrés Mora, O. Maiz-Alonso, Monica Calderón-Goercke, Arantxa Conesa, Beatriz Valls-Espinosa, Verónica Rodriguez-Mendez, Valvanera Pinillos, Diana Peiteado, José Luis Martín-Varillas, Belén Atienza-Mateo, Vega Jovani, I. González-Mazón, Ana Blanco, E. Tomero Muriel, Ángel García-Aparicio, Elena Aurrecoechea, R. Demetrio-Pablo, I. Torre-Salaberri, Diana Prieto-Peña, Juan A. Troyano, L. Sanchez-Bilbao, Margarita Sánchez-Orgaz, D. Martínez-López
Publikováno v:
Annals of the Rheumatic Diseases. 79:850-851
Background:Tocilizumab (TCZ) has shown promising results in the treatment of inflammatory ocular disease, especially in uveitis (1-3). Graves orbitopathy (GO) is the most common complication of Graves’ disease (GD). Conventional immunosuppressive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b681cf03020ef7538a67b891361b097
https://doi.org/10.1136/annrheumdis-2020-eular.3651
https://doi.org/10.1136/annrheumdis-2020-eular.3651
Autor:
Ana Urruticoechea-Arana, I. Torre-Salaberri, Susana Romero-Yuste, Sheila Castro, Ricardo Blanco, P. Rubio Muñoz, P. Fanlo, José L. Hernández, Á. García Martos, Cristina Fernández-Carballido, O. Martínez González, L. Sanchez-Bilbao, A. García-Valle, J. De Dios-Jiménez Aberásturi, A. Sanchez-Andrade, Miguel Cordero-Coma, Vega Jovani, Marisa Hernández-Garfella, E. Peña Sainz-Pardo, P. Moya, I. González-Mazón, O. Maíz, José Luis Martín-Varillas, Ángel García-Aparicio, R. Veroz Gonzalez, S. Rodríguez Montero, Vanesa Calvo-Río, Emma Beltrán, I. Hernanz Rodríguez, Arantxa Conesa, Alfredo Adán, R. Miguélez, A. Gallego, M. A. González-Gay
Publikováno v:
Annals of the Rheumatic Diseases. 80:952-952
Background:Prognosis of non-infectious refractory uveitis has improved markedly with biologic therapy (BT) (1-5). Most data are with monoclonal anti-TNF drugs, especially Adalimumab (ADA) and Infliximab (IFX). However, there is not enough evidence fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714cc97adeba7e97293c74c984079fdb
https://doi.org/10.1136/annrheumdis-2021-eular.1233
https://doi.org/10.1136/annrheumdis-2021-eular.1233
Autor:
I. Braña Abascal, J. Malave Calzada, R. Veroz Gonzalez, M. D. C. Carrasco Cubero, S. M. Rojas Herrera, J. J. Aznar Sanchez, M. Priego Fernandez-Martos, L. M. Chaves Chaparro, D. Fernandez Lozano, E. Chamizo Carmona
Publikováno v:
Annals of the Rheumatic Diseases. 79:286.3-286
Background:The estimated prevalece of osteporosis in lumbar spine in women over 50 years is around 22.8% of the general population. In women with rheumatoid arthritis (RA), osteoporosis (OP) is more prevalent and begins at earlier ages.Objectives:The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6792b9343e1bd9928542df75d5cad777
https://doi.org/10.1136/annrheumdis-2020-eular.3293
https://doi.org/10.1136/annrheumdis-2020-eular.3293
Autor:
I. Torre-Salaberri, A. García-Valle, J. De Dios-Jiménez Aberásturi, I. González-Mazón, Vanesa Calvo-Río, Arantxa Conesa, P. Rubio Muñoz, O. Maíz, R. Veroz Gonzalez, Á. García Martos, Ana Urruticoechea-Arana, Belén Atienza-Mateo, A. Sanchez-Andrade, Marisa Hernández-Garfella, O. Martínez González, M. A. González-Gay, Ángel García-Aparicio, José Luis Martín-Varillas, S. Rodríguez Montero, L. Sanchez-Bilbao, Roman Blanco, Vega Jovani, R. Miguélez
Publikováno v:
Annals of the Rheumatic Diseases. 79:384.2-385
Background:Infliximab and adalimumab therapy has significantly improved the prognosis of patients with non-infectious refractory uveitis. However, there is not enough evidence for the use of other anti-TNF drugs such as Certolizumab Pegol (CZP).Objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6387bb9e0d1939340725034ca673a2c6
https://doi.org/10.1136/annrheumdis-2020-eular.6367
https://doi.org/10.1136/annrheumdis-2020-eular.6367
Autor:
J. J. Aznar Sanchez, J. Malave Calzada, M. Priego Fernandez-Martos, D. Fernandez Lozano, R. Veroz Gonzalez, E. Chamizo Carmona, I. Braña Abascal, S. M. Rojas Herrera
Publikováno v:
Annals of the Rheumatic Diseases. 79:1670.3-1671
Background:Cardiovascular diseases are more prevalent in inflammatory arthritis, such as psoriatic arthropathy (PsA), than in general population. An increase in the presence of anxiety-depressive disorders has been also described in patients with pso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede561f03e5be85303fac06618d4ab2c
https://doi.org/10.1136/annrheumdis-2020-eular.6410
https://doi.org/10.1136/annrheumdis-2020-eular.6410